TCA
DXCM icon

Trifecta Capital Advisors’s DexCom DXCM Stock Holding History

Trifecta Capital Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-13
Closed -$888 – 485
2025
Q1 		$888 Hold
13
– – ﹤0.01% 385
2024
Q4 		$1.01K Sell
13
-5
-28% -$370 ﹤0.01% 370
2024
Q3 		$1.21K Hold
18
– – ﹤0.01% 361
2024
Q2 		$2.04K Hold
18
– – ﹤0.01% 311
2024
Q1 		$2.5K Hold
18
– – ﹤0.01% 281
2023
Q4 		$2.23K Buy
18
+8
+80% +$817 ﹤0.01% 316
2023
Q3 		$933 Hold
10
– – ﹤0.01% 376
2023
Q2 		$1.29K Hold
10
– – ﹤0.01% 356
2023
Q1 		$1.16K Hold
10
– – ﹤0.01% 357
2022
Q4 		$1.13K Buy
+10
New +$1.1K ﹤0.01% 368

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Trifecta Capital Advisors's DXCM Position: Q2 2025 in Review

Trifecta Capital Advisors sold out of DexCom (DXCM) in Q2 2025, closing a stake of 13 shares — an estimated $888 sold.

Trifecta Capital Advisors first reported a position in DXCM in Q4 2022 and held it in 10 quarters. The position peaked at $2.5K in Q1 2024. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • Trifecta Capital Advisors reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • Trifecta Capital Advisors sold 13 DexCom shares in Q2 2025, an estimated $888.
  • Trifecta Capital Advisors first reported a position in DexCom in Q4 2022 and held it in 10 quarters.
  • Trifecta Capital Advisors's DexCom position peaked at $2.5K in Q1 2024.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Trifecta Capital Advisors's 13F filing for Q2 2025, filed 23 Jul 2025.